GlassScriptPhysician profile
Jeffrey Visotsky
NPI 1669428538
$1,141,389.19
in general payments reported to CMS, 2019-2025
14 companies · $2,677 in 2025
The $2,677 reported for 2025 was more than what 86% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $978K · 2021: $119K · 2022: $11K · 2023: $30K · 2024: $140 · 2025: $2,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $32K · Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $32,321.31 |
| Food and Beverage | $360.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $978,008.94 | 2020 | |
| Medtronic, INC. | $162,526.10 | 2021-2025 | Ellipsys Vascular Access System |
| Axogen | $226.77 | 2019-2023 | Avance Nerve Graft |
| Horizon Therapeutics Plc | $168.13 | 2019-2021 | |
| Amgen INC. | $140.05 | 2024 | Krystexxa |
| Bioventus LLC | $84.46 | 2020 | |
| Depuy Synthes Sales INC. | $67.24 | 2022 | |
| Smith+Nephew, INC. | $66.45 | 2025 | Stravix Pl, Oasis |
| Vertex Pharmaceuticals Incorporated | $40.73 | 2025 | |
| Pfizer INC. | $26.85 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.66 | 2022 | |
| Ermi LLC | $14.81 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$396,880.82 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Visotsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.